Background: Mutations in pncA and gyrA genes cause pyrazinamide (PZA) and fluroquinolone resistance in Mycobacterium tuberculosis (MTB). In the present study, structures of pyrazinamidase (PZase) and DNA gyrase proteins were studied in resistant and susceptible clinical isolates of MTB. Materials and Methods: Sixty clinical isolates of MTB were used in this study. Polymerase chain reaction (PCR) amplification of pncA and gyrA genes was accomplished on purified DNA. Sequence of the fragments was determined by an Applied Biosystems TM apparatus. Bioinformatic analysis was performed by online software and three-dimensional (3D) structures of proteins was predicted using Molegro Virtual Docker (MVD) Modeler software. Results: Amplified 744 and 194 bp fragments of pncA and gyrA genes, respectively were yielded suitable sequence results. Predicted 3D structures of proteins showed some differences between wild-type and mutant structures. Mutation in amino acid No.31 (T92C) caused an increase in distance from metal ion position to enzyme active site, but it was considered as a polymorphism. Docking results by MVD revealed a relationship in quinolone resistancedetermining regions (QRDR) amino acids in interaction with antibiotic. T92C mutation in PZase from non-polar aliphatic amino acid Ile (ATC) to polar aliphatic amino acid threonine (ACC) was a polymorphism. Conclusion: Structural changes in two important proteins related to drug resistance were proven in clinical isolates of MTB.
INTRODUCTION
Pyrazinamide, a nicotinamide analog, is one of the most important first line drugs for treatment of MTB infections.
Pyrazinamide is bactericidal to MTB and reduces the tuberculosis treatment time (1) , because PZA appears to kill at least 95% of the semi-dormant bacterial population, since its activity is present only in the acidic environment found in active inflammation (2) . Pyrazinamide is a prodrug that must be activated by a bacterial PZase to the active form i.e. pyrazinoic acid, which is toxic for MTB (3, 4) .
Mutations in the pncA gene causing PZA resistance (5) occur along the entire pncA gene open reading frame and in its putative regulatory region (1) . These mutations lead to loss of PZase activity and limit its effectiveness.
TANAFFOS
Any change in the pncA gene, may cause PZA resistance in these bacteria (6) (7) (8) (9) (10) (11) . Somoskovi et al. (6) They found that more than 42% of the mutations occurred exclusively in both nucleotides 359 and 374 (11) .
During the process of replication and transcription, the opening DNA leads to the production of positive and negative super coils. Topoisomerase openes these supercoils that are created in front of replication forks.
Gyrase enzyme can be attached to a piece of DNA called G segment. ATP binding leads to a near two-domain enzyme and changes its three dimensional structure. Then, it cuts both strands of a DNA G segment and connects the other two strands of the T segment. ATP binds to the two ATPase domains of Topoisomerase II and dimerises them. 
MATERIALS AND METHODS

Bacterial Samples
A total of 60 clinical strains of MTB were isolated from sputum samples of patients with tuberculosis. All specimens were processed for drug susceptibility testproportion method. DNA Extraction was carried out by Chelex 100 (Sigma, USA) method.
PCR Amplification of pncA and gyrA
The extracted DNA was amplified using pncA primers 
DNA Sequencing
The purified PCR product was sequenced in an automated DNA Sequencer ABI PRISM® 310 Genetic
Analyzer. The nucleotide sequences obtained were aligned and analyzed by Chromas, BLASTx and MEGA software to identify the amino acid changes in comparison with the wild type MTB (H37Rv).
Bioinformatic analysis
Nucleotide sequence alignments were carried out using 
RESULTS
Sixty clinical isolates of MTB were studied to detect any mutations in the pncA gene. In vitro susceptibility testing showed that 39 of these isolates were resistant to PZA. The In accordance with the distance and position of active protein, and no correlation between amino acid 31 and other amino acids in the active site position, structural stability of mutation is acceptable; therefore it can be considered as a polymorphism. Comparison of these distances is shown in Table 1 .
Identification of the secondary structures and amino acids involved in the activation of gyrase protein was performed by MVD ( Figure 3 ). Alfa-helix and beta-sheet were shown in amino acid sequencing (Figure 3 ) as bold lines and the arrows, respectively. Distance and orientation of the amino acids can be considered as criteria for their importance in activity of the enzyme (Figures 6, 7) . As shown in Figure 6 , due to long distance and specific orientation of amino acid 95 compared to amino acid 94, any change at 95 would be polymorphism and not related to resistance.
DISCUSSION
In this study, amplification of the two pncA and gyrA replication and lead to cell death (7, 14) . As it can be illustrated, distance and direction of amino acid 95 is in a way that it cannot be involved in drug bonding, and the mutation here will be polymorphism; in contrast, amino acid 94 is one important involved amino acid in drug bonding with DNA.
Considering the occurrence of peptide bonds between theY93 and D94, distances and directions in formation of these bonds, it was suggested that these two amino acids were placed in enzyme active site. Furthermore, any changes in codon 94 would be changed the distances of peptide bonds (θ, ψ) and orientation of tyrosine 93 within the enzyme active site. Validation of detected changes with sequencing method in the isolates with mutated phenotypes can be showed accurate of these predictions.
CONCLUSION
In this study, alterations in structural proteins of Pzase and quinolone were found to be related to drug resistance in clinical isolates of MTB. Any changes leading to polymorphism or drug resistance validated by sequencing were predicted in the proteins by the bioinformatics tools.
This finding are important for more effective diagnosis and treatment of tuberculosis.
